ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2846

Baseline Work Participation Of a Novel Intervention To Prevent Work Disability Among Persons With Arthritis: The “Work it” Study

Rawan Alheresh1, Saralynn H. Allaire2, Michael P. Lavalley3,4, Mary Vaughan1 and Julie J. Keysor5, 1Boston University Sargent College, Boston, MA, 2Clinical Epidemiology Research, Boston Univ School of Medicine, Boston, MA, 3Biostatistics, Boston University School of Public Health, Boston, MA, 4Biostatistics, Boston University, Boston, MA, 5Physical Therapy, Boston University Sargent College, Boston, MA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Employment, Work Disability and rehabilitation

  • Tweet
  • Email
  • Print
Session Information

Title: Education/Community Programs

Session Type: Abstract Submissions (ARHP)

Background/Purpose: People with arthritis are at risk of work disability. Job accommodation and educational programs delivered before imminent work loss can minimize work disability, yet are not widely implemented. The Work It Study is a randomized controlled trial testing the efficacy of a work barrier problem solving program delivered by physical and occupational therapists to prevent work loss over a two year period among people with arthritis and rheumatological conditions (i.e. lupus, fibromyalgia and scleroderma) who are concerned about their ability to continue working due to their health. The purpose of this abstract is to describe the baseline work participation status of the subjects.

Methods: Eligibility criteria: age 23-65, self-report of physician diagnosed arthritis or rheumatic condition, report of “any concern about working now or in the near future due to your health”, working at least 15 hours a week, plans to continue working, and work or live in Massachusetts. Subjects were recruited through community sources, rheumatology offices, and a medical registry. Work participation was measured at baseline. Self-reported data collected by telephone included i) work status/work hours, ii) number days off from work due to arthritis, iii) Work Limitation Questionnaire (WLQ), iv) WHO Health and Work Performance Questionnaire (HPQ), and v) Work Maintenance Self-Efficacy Questionnaire (WMSEQ). Other baseline data included visual analogue scales of pain, fatigue, stress, and job satisfaction, physical function (Health Assessment Questionnaire) and demographics (e.g., age, gender, ethnicity, education, and marital status), self-report diagnosis of arthritis or rheumatological condition.
Results: 428 people screened to date; 177 completed baseline data collection and were randomized. The mean age of the sample is 50 years old, 65% are white, and the majority are female. All participants were employed at baseline and worked 36.7 hours a week on average and had 3.4 days away from work due to arthritis in the past 3 months. The WLQ- output demand scale score showed respondents were limited on-the-job 48% of time in the past two weeks (SD=27.9; 0 least limited, 100 most limited). The HPQ presenteeism score was 1.04 (SD=0.34; 0.25 least productive, 2.0 most productive).  The WMSEQ score was 2.85 (SD=0.70; 0 least confident, 3 most confident). Demographic and clinical variables are listed in Table 1.

Conclusion: To date, the Work It sample seems to have presenteeism work limitations and high pain, fatigue, and stress. Thus, participants seem to be at risk of increasing work disability over the upcoming few years.

 

Table 1. Descriptive statistics of the Work-It sample (n=177)

Variable

Mean or Percent

Age (in years)

49.9 (SD: 10.9)

Sex

 

             Female

77.8%

             Male

22.2%

Race

 

              White

65.4%

            Black

24.6%

            American Indian/ Alaska Native

2.23%

            Asian/other pacific Islander

2.79%

            Mixed/Other        

5.03%

Education

 

            Some high school

1.7%

            High school

11.7%

            Some college

25.0%

            College

30.0%

            Some graduate

5.0%

            Graduate

26.7%

Marital Status- Married

35.0%

Self-Reported Arthritis or Rheumatic Condition

 

Osteoarthritis

40.4%

Rheumatoid Arthritis

23.6%

Lupus

12.3%

Fibromyalgia

12.3%

Psoriatic Arthritis

3%

Other

8.4%

Pain VAS* (0 the least, 10 the most)

6.2 (SD: 2.16)

Fatigue VAS*  (0 the least, 10 the most)

6.8 (SD: 1.98)

Stress VAS* (0 the least, 10 the most)

6.3 (SD:2.55)

Job Satisfaction* VAS (0 the least, 10 the most)

6.5 (SD:2.76)

HAQ** Score (0 the least, 3 the most)

0.82 (SD:0.47)

* Visual Analogue Scale

**HAQ: Health Assessment Questionnaire, the higher score indicates greater disability

 

 


Disclosure:

R. Alheresh,
None;

S. H. Allaire,
None;

M. P. Lavalley,
None;

M. Vaughan,
None;

J. J. Keysor,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/baseline-work-participation-of-a-novel-intervention-to-prevent-work-disability-among-persons-with-arthritis-the-work-it-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology